高级检索
当前位置: 首页 > 详情页

Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. [2]Department of Utrsound, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. [3]State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, China. [4]Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. [5]Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China. [6]Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, P. R. China. [7]National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Hunan, China.
出处:
ISSN:

摘要:
Many survivors of a first primary cancer (FPCs) are at risk of developing a second primary cancer (SPC), with effects on patient prognosis. Primary cancers have different frequencies of specific SPC development and the development of SPCs may be closely related to the FPC. The aim of this study was to explore possible correlations between SPCs and FPCs.Relevant literature on SPCs was retrospectively searched and screened from four databases, namely, PubMed, EMBASE, Web of Science, and PMC. Data on the number of patients with SPC in 28 different organ sites were also collected from The Surveillance, Epidemiology, and End Results (SEER) 8 Registry and NHANES database.A total of 9 617 643 patients with an FPC and 677 430 patients with an SPC were included in the meta-analysis. Patients with a first primary gynaecological cancer and thyroid cancer frequently developed a second primary breast cancer and colorectal cancer. Moreover, those with a first primary head and neck cancer, anal cancer and oesophageal cancer developed a second primary lung cancer more frequently. A second primary lung cancer and prostate cancer was also common among patients with first primary bladder cancer and penile cancer. Patients with second primary bladder cancer accounted for 56% of first primary ureteral cancer patients with SPCs.This study recommends close clinical follow-up, monitoring and appropriate interventions in patients with relevant FPCs for better screening and early diagnosis of SPCs.© The Author(s) 2023. Published by Oxford University Press on behalf of BJS Society Ltd. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 1 区 医学
小类 | 1 区 外科
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 外科
JCR分区:
出版当年[2023]版:
Q1 SURGERY
最新[2023]版:
Q1 SURGERY

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2023版]

第一作者:
第一作者机构: [1]Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. [2]Department of Utrsound, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. [6]Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, P. R. China. [7]National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Hunan, China. [*1]Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China [*2]National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China [*3]Department of Oncology, Zhujiang Hospital, Southern Medical University, 253 Industrial Avenue, Guangzhou, 510282 Guangdong, China [*4]Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu 611731, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43389 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号